Novavax Initiates Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Novavax Initiates Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.00 +0.65 (6.95%)
Previous Close $9.35    52 Week High $9.23 
Open $9.61    52 Week Low $1.16 
Day High $10.38    P/E N/A 
Day Low $9.61    EPS $-0.30 
Volume 8,876,153